oxybutynin has been researched along with Anochlesia in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rasagiline mesylate is used as first line agent for early management of Parkinson's disease but its water soluble nature creates hurdles to cross blood brain barrier also its low oral bioavailability and rapid elimination requires frequent dosing." | 1.56 | Impact of rasagiline nanoparticles on brain targeting efficiency via gellan gum based transdermal patch: A nanotheranostic perspective for Parkinsonism. ( Bali, NR; Salve, PS, 2020) |
| "We previously reported the induction of catalepsy by amiodarone, aprindine and procaine, which possess a diethylaminomethyl moiety and demonstrated selective blockade of dopamine D2 receptors by these drugs in mice." | 1.31 | Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice. ( Hattori, F; Inoue, N; Matsui, A; Matsuo, H; Nasu, R; Ohtani, H; Sawada, Y; Takanaga, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuo, H | 1 |
| Matsui, A | 1 |
| Nasu, R | 1 |
| Takanaga, H | 1 |
| Inoue, N | 1 |
| Hattori, F | 1 |
| Ohtani, H | 1 |
| Sawada, Y | 1 |
| Bali, NR | 1 |
| Salve, PS | 1 |
2 other studies available for oxybutynin and Anochlesia
| Article | Year |
|---|---|
Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice.
Topics: Animals; Antitussive Agents; Benzilates; Catalepsy; Cholinergic Antagonists; Cyclopentanes; Male; Ma | 2000 |
Impact of rasagiline nanoparticles on brain targeting efficiency via gellan gum based transdermal patch: A nanotheranostic perspective for Parkinsonism.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Behavior, Animal; Brain; Catalepsy; Diffus | 2020 |